HomeOpen Access NewsNeurodegenerative Diseases

Neurodegenerative Diseases

Harvard wearable robot provides personalised support for stroke and ALS patients

Harvard engineers have pioneered a unique wearable robot that adapts to user movements, providing personalised assistance to enhance daily activities for stroke and ALS patients.

The impact and importance of psychedelic medicine

Here, we discover the impact and importance of psychedelic medicine through the eyes of Amanda Feilding, Director of The Beckley Foundation.

Patient and Public Involvement at the heart of brain research

Professor Mogens Hørder, PPI expert, JPND’s management board member and representative of member state Denmark, discusses how Patient and Public Involvement (PPI) is at the heart of neurodegenerative disease research.

Supporting families living with Huntington’s Disease

Chief Executive of the Huntington’s Disease Association, Cath Stanley, maps out the charities ongoing work to support its community, despite the COVID-19 pandemic.

Investing in the future of neuroscience

Nina Schor, Deputy Director and Acting Scientific Director of NINDS, underlines the importance of investing in the future of neuroscience.

Finnish scientists invent blood test for dementia

A new study by the University of Eastern Finland finds that a blood test could help to diagnose patients with frontotemporal dementia.

Indiana team explores nanoparticle cure for neurological disorders

Indiana University School of Medicine researchers are attempting to use magnetic nanoparticles to develop a cure for neurological disorders from epilepsy to Alzheimer's - without any invasive or genetic treatment.

Novel digital biomarkers to aid in the diagnosis and tracking of symptoms in patients with Parkinson’s Disease

Dr Rutger Zietsma – CEO at Manus Neurodynamica Ltd – and PD Dr Angela Deutschländer share their vision on earlier diagnosis and objective symptom tracking with the NeuroMotor PenTM.

JPND: Enabling collaborative research in Alzheimer’s and Parkinson’s diseases

Professor of Neurology Thomas Gasser, JPND’s Scientific Advisory Board Chair and Director of the Department of Neurodegenerative Diseases, shares in an interview JPND’s innovative research and collaboration efforts in the universal race against Alzheimer’s and Parkinson’s diseases.

Understanding the many possible paths to dementia

Dr Roderick Corriveau, PhD from the National Institute of Neurological Disorders & Stroke, part of the National Institutes of Health in the U.S., details the importance of understanding the many possible paths to dementia.

Huntington’s disease (HD) research

Dr. James E Goldman and Dr. Osama Al-Dalahmah from the Department of Pathology and Cell Biology at Columbia University, provide an in-depth perspective on Huntington’s disease (HD) research.

Identifying dementia & mild cognitive impairment

Dr Timothy Kwok, Professor at The Chinese University of Hong Kong, shares the development of the Electronic Cognitive Screen (EC-Screen) for population screening of dementia in older people.

What is the connection between pain and memory?

Researchers are investigating how everyday pain impacts memory - specifically, how do these daily experiences impact the way we think? 

Creating a major impact on neurodegenerative research funding in Europe

JPND, the largest global collaborative initiative for neurodegenerative disease research, creates a major impact on neurodegenerative research funding in Europe.

Brain conditions, mental and neurological alike

Prof Monica Di Luca, President, European Brain Council, sheds light on brain conditions, mental and neurological alike, starting with comment on the burdens presented.

New treatment that ‘stuns’ arthritis pain could reduce opiate use

Over 350 million people suffer from arthritis pain globally, which means significant levels of opiates are used to manage the condition - but what if there was a less addictive treatment?

Dementia Tech: Overcoming barriers to innovation post-pandemic

Daniel Berman from Nesta Challenges and Colin Capper at the Alzheimer’s Society focus here on dementia tech, including comment on overcoming barriers to innovation post-pandemic.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders